1 Oral Thin Film Drugs Market Overview
1.1 Product Overview and Scope of Oral Thin Film Drugs
1.2 Oral Thin Film Drugs Segment by Type
1.2.1 Global Oral Thin Film Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Sublingual Film
1.2.3 Fully Dissolving Dental/Buccal Film
1.3 Oral Thin Film Drugs Segment by Application
1.3.1 Global Oral Thin Film Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Schizophrenia
1.3.3 Migraine
1.3.4 Opioid Dependence
1.3.5 Nausea & Vomiting
1.3.6 Others
1.4 Global Oral Thin Film Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral Thin Film Drugs Revenue 2017-2028
1.4.2 Global Oral Thin Film Drugs Sales 2017-2028
1.4.3 Oral Thin Film Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral Thin Film Drugs Market Competition by Manufacturers
2.1 Global Oral Thin Film Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oral Thin Film Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oral Thin Film Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oral Thin Film Drugs Manufacturing Sites, Area Served, Product Type
2.5 Oral Thin Film Drugs Market Competitive Situation and Trends
2.5.1 Oral Thin Film Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Thin Film Drugs Players Market Share by Revenue
2.5.3 Global Oral Thin Film Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Thin Film Drugs Retrospective Market Scenario by Region
3.1 Global Oral Thin Film Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oral Thin Film Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oral Thin Film Drugs Market Facts & Figures by Country
3.3.1 North America Oral Thin Film Drugs Sales by Country
3.3.2 North America Oral Thin Film Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oral Thin Film Drugs Market Facts & Figures by Country
3.4.1 Europe Oral Thin Film Drugs Sales by Country
3.4.2 Europe Oral Thin Film Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Thin Film Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Thin Film Drugs Sales by Region
3.5.2 Asia Pacific Oral Thin Film Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oral Thin Film Drugs Market Facts & Figures by Country
3.6.1 Latin America Oral Thin Film Drugs Sales by Country
3.6.2 Latin America Oral Thin Film Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Thin Film Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Thin Film Drugs Sales by Country
3.7.2 Middle East and Africa Oral Thin Film Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oral Thin Film Drugs Historic Market Analysis by Type
4.1 Global Oral Thin Film Drugs Sales Market Share by Type (2017-2022)
4.2 Global Oral Thin Film Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Oral Thin Film Drugs Price by Type (2017-2022)
5 Global Oral Thin Film Drugs Historic Market Analysis by Application
5.1 Global Oral Thin Film Drugs Sales Market Share by Application (2017-2022)
5.2 Global Oral Thin Film Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Oral Thin Film Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sumitomo Dainippon Pharma Co., Ltd.
6.1.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
6.1.2 Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
6.1.3 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Product Portfolio
6.1.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer Oral Thin Film Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis AG Oral Thin Film Drugs Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 ZIM Laboratories Limited
6.4.1 ZIM Laboratories Limited Corporation Information
6.4.2 ZIM Laboratories Limited Description and Business Overview
6.4.3 ZIM Laboratories Limited Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 ZIM Laboratories Limited Oral Thin Film Drugs Product Portfolio
6.4.5 ZIM Laboratories Limited Recent Developments/Updates
6.5 Indivior Plc.
6.5.1 Indivior Plc. Corporation Information
6.5.2 Indivior Plc. Description and Business Overview
6.5.3 Indivior Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Indivior Plc. Oral Thin Film Drugs Product Portfolio
6.5.5 Indivior Plc. Recent Developments/Updates
6.6 Allergan Plc.
6.6.1 Allergan Plc. Corporation Information
6.6.2 Allergan Plc. Description and Business Overview
6.6.3 Allergan Plc. Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Allergan Plc. Oral Thin Film Drugs Product Portfolio
6.6.5 Allergan Plc. Recent Developments/Updates
6.7 IntelGenx Corp
6.6.1 IntelGenx Corp Corporation Information
6.6.2 IntelGenx Corp Description and Business Overview
6.6.3 IntelGenx Corp Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 IntelGenx Corp Oral Thin Film Drugs Product Portfolio
6.7.5 IntelGenx Corp Recent Developments/Updates
6.8 NAL Pharma
6.8.1 NAL Pharma Corporation Information
6.8.2 NAL Pharma Description and Business Overview
6.8.3 NAL Pharma Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 NAL Pharma Oral Thin Film Drugs Product Portfolio
6.8.5 NAL Pharma Recent Developments/Updates
6.9 Wolters Kluwer
6.9.1 Wolters Kluwer Corporation Information
6.9.2 Wolters Kluwer Description and Business Overview
6.9.3 Wolters Kluwer Oral Thin Film Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Wolters Kluwer Oral Thin Film Drugs Product Portfolio
6.9.5 Wolters Kluwer Recent Developments/Updates
7 Oral Thin Film Drugs Manufacturing Cost Analysis
7.1 Oral Thin Film Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Thin Film Drugs
7.4 Oral Thin Film Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Thin Film Drugs Distributors List
8.3 Oral Thin Film Drugs Customers
9 Oral Thin Film Drugs Market Dynamics
9.1 Oral Thin Film Drugs Industry Trends
9.2 Oral Thin Film Drugs Market Drivers
9.3 Oral Thin Film Drugs Market Challenges
9.4 Oral Thin Film Drugs Market Restraints
10 Global Market Forecast
10.1 Oral Thin Film Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Thin Film Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oral Thin Film Drugs by Type (2023-2028)
10.2 Oral Thin Film Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Thin Film Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oral Thin Film Drugs by Application (2023-2028)
10.3 Oral Thin Film Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Thin Film Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oral Thin Film Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer